{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:43:54Z","timestamp":1792118634952,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.leukres.2026.108344","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:54:46Z","timestamp":1791906886000},"page":"108344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pediatric-inspired USC-ALL regimen vs hyper-CVAD in adults with Ph-negative and Ph-like acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0269-0993","authenticated-orcid":false,"given":"Anush A.","family":"Ginosyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam","family":"Ashouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7856-495X","authenticated-orcid":false,"given":"Andrew","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7434-7144","authenticated-orcid":false,"given":"Elaine","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7995-6062","authenticated-orcid":false,"given":"Brian","family":"Hom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1091-656X","authenticated-orcid":false,"given":"Brandon","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsine","family":"Kolanjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Begur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Nittur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7745-2476","authenticated-orcid":false,"given":"Blake","family":"Adnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollee","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karrune","family":"Woan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Leon","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-3556","authenticated-orcid":false,"given":"George","family":"Yaghmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2026.108344_bib1","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.4081\/hr.2021.8847","article-title":"Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age","volume":"13","author":"Devilli","year":"2021","journal-title":"Hematol. Rep."},{"issue":"14","key":"10.1016\/j.leukres.2026.108344_bib2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2026.108344_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/leu.2014.229","article-title":"Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia","volume":"29","author":"DeAngelo","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2026.108344_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamaoncol.2017.5305","article-title":"Pediatric-inspired treatment regimens for adolescents and young adults with philadelphia chromosome-negative acute lymphoblastic leukemia: a review","volume":"4","author":"Siegel","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108344_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/hematology.2019000009","article-title":"Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit?","volume":"2019","author":"Muffly","year":"2019","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"issue":"12","key":"10.1016\/j.leukres.2026.108344_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11864-022-01032-5","article-title":"Central nervous system prophylaxis and treatment in acute leukemias","volume":"23","author":"Wu","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108344_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clml.2020.09.001","article-title":"The Hyper-CVAD regimen is an optimal pediatric-inspired regimen for adolescents and adults with acute lymphoblastic leukemia","volume":"21","author":"Jabbour","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"10","key":"10.1016\/j.leukres.2026.108344_bib8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ajh.25229","article-title":"Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens","volume":"93","author":"Siegel","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108344_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/ajh.27607","article-title":"The efficacy of pediatric-inspired regimens vs. hyper-CVAD in the treatment of adolescents and young adults with acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"100","author":"Su","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108344_bib10","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025018736","article-title":"Pediatric-inspired regimens & HSCT for adolescents & young adults with acute lymphoblastic leukemia: systematic reviews","author":"Sereda","year":"2026","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.leukres.2026.108344_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2026.108344_bib12","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1111\/bjh.19771","article-title":"Philadelphia-like B-cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapy","volume":"205","author":"Ashouri","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108344_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clml.2016.09.003","article-title":"Acute leukemia characteristics are different around the world: the mexican perspective","volume":"17","author":"G\u00f3mez-Almaguer","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.leukres.2026.108344_bib14","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/cam4.1513","article-title":"Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA)","volume":"7","author":"Crespo-Solis","year":"2018","journal-title":"Cancer Med."},{"issue":"19","key":"10.1016\/j.leukres.2026.108344_bib15","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"130","author":"Tasian","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2026.108344_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.383","article-title":"Measurable residual disease detection in B-acute lymphoblastic leukemia: the Children's Oncology Group (COG) Method","volume":"2","author":"Borowitz","year":"2022","journal-title":"Curr. Protoc."},{"issue":"1","key":"10.1016\/j.leukres.2026.108344_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cyto.b.21482","article-title":"A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia\/lymphoma post anti-CD19 therapy","volume":"94","author":"Cherian","year":"2018","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.leukres.2026.108344_bib18","unstructured":"Team RC. R.: A Language and Environment for Statistical Computing. In: Computing RFfS, editor. Vienna, Austria 2023."},{"issue":"1","key":"10.1016\/j.leukres.2026.108344_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/asheducation-2017.1.13","article-title":"Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation","volume":"2017","author":"Br\u00fcggemann","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"issue":"6","key":"10.1016\/j.leukres.2026.108344_bib20","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/bloodadvances.2024015441","article-title":"Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts","volume":"9","author":"Short","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2026.108344_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107316","article-title":"Comparison of a modified pediatric protocol versus a hyper-CVAD protocol in adolescents and young adults with Philadelphia-negative acute lymphoblastic leukemia: a multicenter retrospective analysis","volume":"130","author":"Salama","year":"2023","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.leukres.2026.108344_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjh.19223","article-title":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","volume":"204","author":"Wang","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2026.108344_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/ejh.14381","article-title":"Hyper-CVAD and modified CALGB-10403 regimens in adult patients with philadelphia-negative acute lymphoblastic leukemia: a comparative study","volume":"114","author":"Zalapa-Soto","year":"2025","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2026.108344_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clml.2016.11.002","article-title":"Hyper-CVAD compared With BFM-like chemotherapy for the treatment of adult acute lymphoblastic leukemia. a retrospective single-center analysis","volume":"17","author":"El-Cheikh","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"8","key":"10.1016\/j.leukres.2026.108344_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ajh.24419","article-title":"Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-M\u00fcnster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen","volume":"91","author":"Rytting","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2026.108344_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jha2.224","article-title":"Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults","volume":"2","author":"Patel","year":"2021","journal-title":"EJHaem"},{"issue":"8","key":"10.1016\/j.leukres.2026.108344_bib27","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3324\/haematol.2020.251686","article-title":"Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia","volume":"106","author":"Geyer","year":"2021","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2026.108344_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ejh.12600","article-title":"Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia","volume":"96","author":"Aldoss","year":"2016","journal-title":"Eur. J. Haematol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108344_bib29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.clml.2021.07.009","article-title":"SOHO state of the art updates and next questions: management of asparaginase toxicity in adolescents and young adults with acute lymphoblastic leukemia","volume":"21","author":"Schmiegelow","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:50:07Z","timestamp":1792115407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626001888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":29,"alternative-id":["S0145212626001888"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108344","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric-inspired USC-ALL regimen vs hyper-CVAD in adults with Ph-negative and Ph-like acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108344"}}